Trimebutine 3-thiocarbamoylbenzenesulfonate

N/A

Report date: 2025/10/27 13:34:47

Base Information

Drug NameTrimebutine 3-thiocarbamoylbenzenesulfonate
Drug Alias NameTB-905-02GIC-1001
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit blockersOpioid receptors agonists
TargetsOpioid receptorsSodium channel alpha subunit
Therapy Area/IndicationsPainColonic DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGicare Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGicare Pharma Inc
Active IndicationsN/A
Inactive IndicationsPainColonic DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A